Current role
Dr. Cameron Turtle
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Cameron Turtle
Spyre Therapeutics, Inc. reported in an 8-K filed October 10, 2023 that Dr. Cameron Turtle was appointed principal executive officer, effective October 6, 2023.
“On October 6, 2023, the Board of Directors (the “Board”) of Aeglea BioTherapeutics, Inc. (the “Company”) appointed Dr. Cameron Turtle, the Company’s Chief Operating Officer, as the principal executive officer of the Company, effective as of the same day.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Spyre Therapeutics, Inc. (SYRE)
SEC 8-K
Current2023-10-06–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Spyre Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Cameron Turtle CEO, COO, Board Member
- Cameron Turtle, DPhil CEO, Board Member
- James Kastenmayer CEO
- Jeffrey M. Goldberg CEO
- Scott Burrows CFO, Chief Accounting Officer
- Heidy Abreu King-Jones General Counsel
- Jonathan Alspaugh Chief Accounting Officer
- Steven Weber Chief Accounting Officer
- Jeffrey Albers Board Member
- Laurie Stelzer Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.